Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by Sdmsdmon Apr 09, 2015 5:17am
185 Views
Post# 23611953

RE:RE:RE:Looking back

RE:RE:RE:Looking back Hello again shorty. I think you have been drinking a little too much of your own cool aid. Your job here is to spread negativity, uncertainty and doubt. You do this by selectively presenting and skewing information but don't try and propose you do it by presentation of ALL the facts.

In making a judgement on an investment, you need to look at ALL available information. Many here, like me, have done this and spoken to the company and have consequently taken the plunge and invested. By no means is this business plan fully derisked but the management team are doing a good job and frankly who cares if from time to time they take a little bit off the table. They deserve it IMO and still (despite your attempts to use this as your wedge issue) have a significant amount riding on its eventual success.

You know you shorty bashers are like a dose of food poisoning. Unexpected, nasty and unpleasant to deal with and with the propensity to linger but ultimately treatable. The treatment in this case will be further news and then the revenues and earnings as they roll in over the coming 12-18 months. You need to understand that many here treat this as an investment and not a short term trading opportunity. 

Now I know that you will have to continue with  the bash for the next couple of weeks but lets agree to review the situation again a year from now and see who has done better. Agree? 

BTW the shares I hold are all free now. Can you say the same about your investment?

Also "thefabergegg'" is a little pretentious for a shorty basher handle isn't ? 
Bullboard Posts